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Introduction
Myeloid-derived suppressor cells (MDSCs) are heteroge-
neous population of immature myeloid cells with
suppressive activity, containing precursor of granulocytes,
macrophages, and dendritic cells [1-3]. They expand in
inflammatory conditions and regulate immune responses.
However, the role that MDSCs played in other chronic
or acute inflammatory conditions like sepsis is not well
understood.
Objectives
To find the role of MDSCs in sepsis and their relationship
with the inflammatory cytokines.
Methods
The model of caecal ligation and puncture (CLP) was used
to induce polymicrobial sepsis in adult male BALB/c mice.
Mice were killed under anesthesia, then blood, peritoneal
lavage fluid, and organs were harvested. After the spleen
MDSCs were isolated, 30 BALB/c mice were randomized
divided into three groups which were CLP+MDSCs
(day3),CLP+MDSCs (day 10), CLP+saline whereas
MDSCs were adoptive transferred into these mice respec-
tively. And the MDSCs accumulation in spleen were
observed at day1,3,6,10.
Results
MDSCs progressively accumulated in spleens during sepsis
in survived mice. They were increasing from ~8% at day 1
to ~50% at day 10. Adoptive transfer of late MDSCs into
naïve mice after CLP could increase the level of IL-10,
decrease the level of INF-g, and improve the survival rate.
Conclusions
MDSCs could influence the inflammation response after
CLP. Contrasting with the deleterious role of MDSCs in
tumor associated diseases, the protective role of these cells
was appeared during the early period of polymicrobial
sepsis. This may provide a new direction for the treatment
of sepsis.
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